Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-530,562
Closed -$149M 37
2025
Q3
$149M Sell
530,562
-159,438
-23% -$40.6M 4.76% 9
2025
Q2
$151M Buy
690,000
+650,000
+1,625% +$105M 5.86% 6
2025
Q1
$5.59M Buy
+40,000
New +$6.51M 0.47% 15
2024
Q4
Sell
-60,000
Closed -$10.2M 52
2024
Q3
$10.2M Buy
+60,000
New +$8.69M 0.58% 21
2023
Q4
Sell
-50,000
Closed -$5.3M 35
2023
Q3
$5.3M Sell
50,000
-1,208,600
-96% -$140M 0.39% 14
2023
Q2
$150M Buy
1,258,600
+1,238,600
+6,193% +$128M 5.16% 8
2023
Q1
$1.86M Hold
20,000
0.14% 15
2022
Q4
$1.64M Sell
20,000
-20,000
-50% -$1.52M 0.2% 11
2022
Q3
$2.44M Buy
+40,000
New +$2.93M 0.84% 11

Other funds holding ORCL

Trivest Advisors's ORCL Position: Q4 2025 in Review

Trivest Advisors sold out of Oracle (ORCL) in Q4 2025, closing a stake of 530,562 shares — an estimated $149M sold.

Trivest Advisors first reported a position in ORCL in Q3 2022 and held it in 9 quarters. The position peaked at $151M in Q2 2025. 3,759 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

  • Trivest Advisors reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
  • Trivest Advisors sold 530,562 Oracle shares in Q4 2025, an estimated $149M.
  • Trivest Advisors first reported a position in Oracle in Q3 2022 and held it in 9 quarters.
  • Trivest Advisors's Oracle position peaked at $151M in Q2 2025.
  • 3,759 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Trivest Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.